You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Aldesleukin

Showing 26 - 50 of 443
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor, Adult Trial in Minneapolis, Hackensack, Houston (FT516, Avelumab, Cyclophosphamide)

Completed
  • Solid Tumor, Adult
  • Minneapolis, Minnesota
  • +2 more
Jan 27, 2023

Metastatic Renal Cell Carcinoma, Metastatic Melanoma Trial in United States (Aldesleukin)

Completed
Has Results
  • Metastatic Renal Cell Carcinoma
  • Metastatic Melanoma
  • Aldesleukin
  • Los Angeles, California
  • +3 more
Jun 4, 2021

Melanoma (Skin), Melanoma in Situ Trial in Halifax (Aldesleukin, Saline)

Suspended
  • Melanoma (Skin)
  • Melanoma in Situ
  • Aldesleukin
  • Saline
  • Halifax, Nova Scotia, Canada
    Queen Elizabeth II Health Sciences Centre
Jul 18, 2022

Gastric Cancer, Breast Cancer, Cervical Cancer Trial in New Brunswick (KK-LC-1 TCR-T cells, Aldesleukin 720,000 IU/kg IV every

Not yet recruiting
  • Gastric Cancer
  • +3 more
  • KK-LC-1 TCR-T cells
  • Aldesleukin 720,000 IU/kg IV every eight hours
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Jul 30, 2022

Melanoma Stage III, Melanoma Stage IV, Inoperable Disease Trial in Tampa (Interleukin-2, Ipilimumab, Nivolumab)

Recruiting
  • Melanoma Stage III
  • +2 more
  • Tampa, Florida
    Moffitt Cancer Center
Dec 6, 2022

Acute Myeloid Leukemia, Acute Myeloid Leukemia Recurrent, Leukemia Trial in Boston (Cytokine-Induced Memory-like Natural Killer

Not yet recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Cytokine-Induced Memory-like Natural Killer Cells
  • +2 more
  • Boston, Massachusetts
  • +1 more
Nov 22, 2023

Acute Myeloid Leukemia, Leukemia, Leukemia, Myeloid Trial in Boston (Cytokine Induced Memory-like Natural Killer Cells,

Not yet recruiting
  • Acute Myeloid Leukemia
  • +5 more
  • Cytokine Induced Memory-like Natural Killer Cells
  • Interleukin-2
  • Boston, Massachusetts
  • +1 more
Nov 14, 2023

Advanced Solid Tumor, Metastatic Cancer Trial in Miranda, Clayton, Heidelberg (AU-007, Aldesleukin)

Recruiting
  • Advanced Solid Tumor
  • Metastatic Cancer
  • Miranda, New South Wales, Australia
  • +2 more
Jun 10, 2022

Metastatic Melanoma, Stage IV Cutaneous Melanoma AJCC v6 and v7 Trial in Houston (biological, drug, other)

Active, not recruiting
  • Metastatic Melanoma
  • Stage IV Cutaneous Melanoma AJCC v6 and v7
  • Aldesleukin
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 2, 2022

HLA-A*0201 Positive Cells Present, NY-ESO-1 Positive Tumor Cells Present, Recurrent Myxoid Liposarcoma Trial in Houston

Active, not recruiting
  • HLA-A*0201 Positive Cells Present
  • +3 more
  • Aldesleukin
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 25, 2022

Acute Coronary Syndromes Trial in Cambridge (Interleukin-2 [IL-2], Placebo Dextrose 5% solution)

Recruiting
  • Acute Coronary Syndromes
  • Interleukin-2 [IL-2]
  • Placebo Dextrose 5% solution
  • Cambridge, Cambridgeshire, United Kingdom
    Addenbrooke's Hospital
May 31, 2022

Endocrine/Neuroendocrine, NSCLC, Breast Cancer Trial run by the National Cancer Institute (NCI) (Fludarabine, Cyclophosphamide,

Recruiting
  • Endocrine/Neuroendocrine
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 24, 2022

Metastatic Melanoma, Stage III Mucosal Melanoma of the Head and Neck, Stage IIIA Skin Melanoma Trial in New Brunswick

Active, not recruiting
  • Metastatic Melanoma
  • +8 more
  • Aldesleukin
  • +2 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Sep 20, 2021

Type1 Diabetes Trial in United Kingdom (Aldesleukin, Placebo)

Active, not recruiting
  • Type1 Diabetes
  • Aldesleukin
  • Placebo
  • Oxford, Oxfordshire, United Kingdom
  • +4 more
Dec 15, 2021

Metastatic Melanoma Trial in Tampa (drug, procedure, biological)

Active, not recruiting
Has Results
  • Metastatic Melanoma
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Nov 8, 2022

Metastatic Melanoma, Skin Cancer Trial run by the National Cancer Institute (NCI) (drug, biological, radiation)

Active, not recruiting
  • Metastatic Melanoma
  • Skin Cancer
  • Aldesleukin
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 24, 2022

HIV Trial in Stanford (Zidovudine, Aldesleukin)

Completed
  • HIV Infections
  • Stanford, California
    Stanford Univ School of Medicine
Oct 27, 2021

HIV Trial in Pittsburgh (Zidovudine, Aldesleukin)

Completed
  • HIV Infections
  • Pittsburgh, Pennsylvania
    Univ of Pittsburgh Med School
Oct 27, 2021

HPV-Associated Cervical Carcinoma, HPV-Related Carcinoma, HPV-Related Malignancy Trial in New Brunswick (Conditioning, E7 TCR-T

Not yet recruiting
  • HPV-Associated Cervical Carcinoma
  • +16 more
  • Conditioning, E7 TCR-T cells, and aldesleukin
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Jan 17, 2023

Covid19 Trial in Ribeirão Preto, Santo André (Ixekizumab, Aldesleukin, Colchicine)

Completed
  • Covid19
  • Ixekizumab
  • +3 more
  • Ribeirão Preto, SP, Brazil
  • +1 more
Jul 26, 2022

NSCLC, Metastatic Non Small Cell Lung Cancer, Stage IV NSCLC Trial in Duarte, Minneapolis (Fludarabine, Cyclophosphamide, CISH

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • +5 more
  • Duarte, California
  • +1 more
Dec 7, 2022

Gynecologic Cancer, Colorectal Cancer, Pancreatic Cancer Trial in Houston (Neoantigen specific TCR-T cell drug product,

Recruiting
  • Gynecologic Cancer
  • +11 more
  • Neoantigen specific TCR-T cell drug product
  • Aldesleukin (IL-2)
  • Houston, Texas
    MD Anderson Cancer Center
Jul 27, 2022

Cancer, Solid Tumor Trial in Houston (drug, biological, diagnostic test)

Completed
  • Cancer
  • Solid Tumor
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 14, 2022

Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8 Trial in Atlanta (Aldesleukin,

Not yet recruiting
  • Lung Non-Small Cell Carcinoma
  • +3 more
  • Aldesleukin
  • Pembrolizumab
  • Atlanta, Georgia
    Emory University/Winship Cancer Institute
Aug 8, 2022

HIV Trial in Pittsburgh (Zidovudine, Aldesleukin)

Completed
  • HIV Infections
  • Pittsburgh, Pennsylvania
    Univ of Pittsburgh Med School
Oct 26, 2021